Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Thrombectomy refers to physical removal of soft thrombus from blood vessels. A thrombectomy device is easy to use and consistently opens blood vessels for the removal of blood clots. Use of thrombectomy devices can improve long-term neurological outcomes by providing higher rates of procedural recanalization. Once recanalization starts, clot softens and partially dissolves, indicating clinical recovery. Thrombectomy devices can be used in patients, where pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate for instance, in case of recent cardiovascular surgery or in patients taking oral anticoagulants.

The global thrombectomy devices market size was estimated to be valued at US$ 1,371.6 Million in 2020, and is expected to witness a CAGR of 7.2% over the forecast period (2020-2027).

Figure 1.Global Thrombectomy Devices Market Value (US$ Million) & Y-o-Y Growth (%), 2020

Thrombectomy Devices  | Coherent Market Insights

The increasing launches of new products and regulatory approvals for thrombectomy devices are expected to propel the growth of the global thrombectomy devices market over the forecast period

For instance, in January 2021, Control Medical Technology announced that the U.S. FDA (Food and Drug Administration) cleared Control 11F Mechanical Thrombectomy system, which is invented to remove large blood clots from patients with deep vein thrombosis (DVT). Furthermore, in May 2020, Control Medical Technology announced that the U.S. FDA cleared Aspire MAX 7 – 11F Mechanical Thrombectomy platform to remove blood clots from peripheral vessels. Moroever, in March 2021, Vetex Medical Ltd. announced that the U.S. Food and Drug Administration (FDA) provided 510 (K) clearance for the ReVene thrombectomy catheter. ReVene uses dual-action technology and is designed to de-clot peripheral vessels including deep vein thrombosis (DVT), in a single session without the use of thrombolytics.

Figure 2. Global Thrombectomy Devices Market Share (%), By Application 2020

Thrombectomy Devices  | Coherent Market Insights

Global Thrombectomy Devices Market – Market Opportunity

Rising development of advance thrombectomy devices and adoption of inorganic growth strategies like acquisition, collaboration, etc., by market players are expected to propel the market growth during the forecast period. For instance, in April 2019, Edwards Lifesciences Corporation acquired CAS Medical Systems, Inc., a medical technology company and developer of non-invasive monitoring of tissue oxygenation in the brain.

request-sample

Thrombectomy Devices Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2020: US$ 1,371.6 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 7.2% 2027 Value Projection: US$ 2,227.7 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices
  • By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Superficial Vein Thrombosis, Renal Vein Thrombosis (RVT), Arterial Thrombosis (Atherothrombosis), Ischemic Stroke, Others
  • By End User: Hospitals, Ambulatory Surgical Centers, Academic and Research Institutes, Others
Companies covered:

LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, Vetex Medical Ltd.

Growth Drivers:
  • Rising demand for minimally invasive thrombectomy procedure
  • Increasing product approvals and launches
Restraints & Challenges:
  • High cost of thrombectomy devices and procedure
  • Low awareness and unavailability of healthcare professionals

Global Thrombectomy Devices Market– Impact of Coronavirus (COVID-19) Pandemic

Governments are taking various initiatives to combat COVID-19. For instance, in May 2020, the Centers for Disease Control and Prevention started working with the All-of-Government and All-of-America Approach (i.e. join activities performed by diverse ministries and public administrations) in order to increase testing capacity of Covid-19, improve case detection, and contact tracing across all countries of the U.S. and to re-open America. The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. Supply of key materials such as probes required for interventional ablation have been severely disrupted due to forced quarantine, and imposed lockdowns in various countries, which has led to disruption in the link between warehouses. This shortage of thrombectomy devices and components used in the thrombectomy procedures have affected the supply chain of the global thrombectomy devices market. The COVID-19 pandemic caused major disruptions to clinical trial execution in the U.S., impacting key stakeholders across the medical devices industry. As per a publication by Medrio, May 2020, an estimated 80% of non-COVID-19 trials were stopped or interrupted as a result of the COVID-19 pandemic.

Global Thrombectomy Devices Market: Restraint

The high cost of thrombectomy devices eventually increases its procedure cost, thereby, affecting adoption of these devices, which is further expected to hinder the market growth. In emerging economies of Africa, Latin America, and Asia Pacific adoption of such expensive procedures is low. For instance, according to data published by the National Institute for Health and Care Excellence (NICE), in July 2018, the cost of mechanical thrombectomy devices worldwide ranged between US$ 700 to US$ 1,719 for aspiration catheters and US$ 1,911 to US$ 6,372 for stent retrievers per unit, excluding taxes. Furthermore, side effects of thrombectomy devices include bleeding from the area, where the catheter is inserted and appearance of bruise in the area causing pain. Moreover, with the breakdown of blood clots, chemicals are released, which can temporarily affect functioning of kidney or heart. Thus, aforementioned factors are expected to hamper market growth during the forecast period.

Key Players

Major players operating in the global thrombectomy devices market include LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, and Vetex Medical Ltd.

Thrombectomy procedures allow surgeons to use a mechanical thrombectomy device such as intracoronary catheters to break up or remove the blood clot and restore normal blood flow in the human body. It helps neurosurgeons to improve patients’ health, especially those experiencing a large artery stroke. Thrombectomy is widely used in major economies of Asia Pacific such as China, India, Australia, and others, due to high number of stroke incidences and increased spending in healthcare. Thrombectomy devices can be used in patients for whom pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate, for instance, in case of recent surgery or in patients who are taking oral anticoagulants.

Market Dynamics

Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. Thrombectomy devices are carefully designed to minimize damage to the vessel wall during a blood clot removal procedure, with minimum blood loss. The rising demand for minimally invasive thrombectomy procedures is expected to drive the growth of the global thrombectomy devices market. For instance, as per a publication by the American Heart Association (AHA) Journals in 2020, patients with COVID-19 suffer from a number of cardiovascular complications, including 16.7% patients suffer from arrhythmia and 23% of patients suffer from heart failure, thus increasing risk for acute ischemic stroke. Cerebrovascular complications have been reported in 5% to 6% of patients with severe COVID-19, globally. This has increased concerns to improve the accessibility and shorten the time to endovascular therapy (EVT) for stroke to give patients better outcome after strokes.

Key features of the study:

  • This report provides in-depth analysis of the global thrombectomy devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global thrombectomy devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, and Vetex Medical Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global thrombectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thrombectomy devices market

Detailed Segmentation:

  • Global Thrombectomy Devices Market, By Product Type:
    • Mechanical Thrombectomy Devices
    • Aspiration Thrombectomy Devices
    • Hydrodynamic Thrombectomy Devices
    • Ultrasonic Thrombectomy Devices
  • Global Thrombectomy Devices Market, By Application:
    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism (PE)
    • Superficial Vein Thrombosis
    • Renal Vein Thrombosis (RVT)
    • Arterial Thrombosis (Atherothrombosis)
    • Ischemic Stroke
    • Others
  • Global Thrombectomy Devices Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Academic and Research Institutes
    • Others
  • Global Thrombectomy Devices Market, By Region:
    • North America
      • By Product Type
        • Aspiration Thrombectomy Devices
        • Stent retriever Thrombectomy Devices
        • Rotational Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Ischemic Stroke
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Academic and Research Institutes
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type
        • Aspiration Thrombectomy Devices
        • Stent retriever Thrombectomy Devices
        • Rotational Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Ischemic Stroke
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Academic and Research Institutes
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type
        • Aspiration Thrombectomy Devices
        • Stent retriever Thrombectomy Devices
        • Rotational Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Ischemic Stroke
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Academic and Research Institutes
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Instruments
        • Aspiration Thrombectomy Devices
        • Stent retriever Thrombectomy Devices
        • Rotational Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Ischemic Stroke
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Academic and Research Institutes
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type
        • Instruments
        • Aspiration Thrombectomy Devices
        • Stent retriever Thrombectomy Devices
        • Rotational Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Ischemic Stroke
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Academic and Research Institutes
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Instruments
        • Aspiration Thrombectomy Devices
        • Stent retriever Thrombectomy Devices
        • Rotational Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Ischemic Stroke
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Academic and Research Institutes
        • Others
      • By Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • LeMaitre Vascular, Inc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boston Scientific Corporation
    • Control Medical Technology
    • Edwards Lifesciences Corporation
    • Johnson & Johnson
    • Medtronic Plc.
    • Merit Medical Systems, Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Penumbra, Inc.
    • Argon Medical Devices
    • Teleflex Incorporated
    • Vetex Medical Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
      • Opportunity Map
  3. Global Thrombectomy Devices Market Dynamics
    • Drivers
    • Restraints
    • Impact Analysis
    • Opportunity
    • Regulatory Scenario
    • Acquisition
    • Epidemiology
    • Technological Overview
    • PEST Analysis
    • Reimbursement Scenario
    • Pricing Analysis, By Product Type
    • Pricing Analysis, By Procedure
  4. Global Thrombectomy Devices Market– Impact of Coronavirus (COVID-19) Pandemic
    • Government Initiatives
    • Impact on Supply and Demand
    • Clinical Trial Impact Analysis
  5. Global Thrombectomy Devices Market, By Product Type, 2016 – 2027, (US$ Million & No. of Procedures)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Mechanical Thrombectomy Devices
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Aspiration Thrombectomy Devices
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Hydrodynamic Thrombectomy Devices
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ultrasonic Thrombectomy Devices
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Thrombectomy Devices Market, By Application, 2016 – 2027, (US$ Million & No. of Procedures)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Deep Vein Thrombosis (DVT)
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Pulmonary Embolism (PE)
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Superficial Vein Thrombosis
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Renal Vein Thrombosis (RVT)
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Arterial Thrombosis (Atherothrombosis)
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ischemic Stroke
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Thrombectomy Devices Market, By End User, 2016 – 2027, (US$ Million & No. of Procedures)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast By Volume and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  8. Global Thrombectomy Devices Market, By Region, 2016 – 2027, (US$ Million & No. of Procedures)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Product Type, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Application, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Application, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Product Type, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Application, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Application, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Product Type, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Application, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Application, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Product Type, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Application, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Application, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Product Type, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Application, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Application, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Product Type, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Application, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Application, 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast By Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  9. Company Profiles
      • LeMaitre Vascular, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Boston Scientific Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Control Medical Technology
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Edwards Lifesciences Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Medtronic Plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Merit Medical Systems, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Stryker Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Terumo Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Penumbra, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Argon Medical Devices
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Teleflex Incorporated
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Vetex Medical Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
  10. Section
    • Contact Us

*Browse 211 market data tables and 79 figures on "Global Thrombectomy Devices Market” - Global forecast to 2027

FAQgrowicon

Frequently Asked Questions

The global thrombectomy devices market is estimated to surpass US$ 1.9 Billion by 2026
Major players operating in the global thrombectomy devices market include Applied Medical, Argon Medical Devices, Inc., Boston Scientific Corporation, BTG International, Capture Vascular, Claret Medical, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., Minnetronix, Inc., Nexgen Medical Systems, Inc., Natec Medical Ltd., Penumbra, Inc., Phenox GmbH, Stentys SA, Spectranetics Corporation, Straub Medical AG, Stryker Corporation, Terumo Corporation, and Teleflex Incorporated
High cost of thrombectomy devices eventually increases its procedure cost and this is one of the major factors that is expected to hamper growth of the market over the forecast period
Increasing incidence of stroke globally is one the major factors that is expected to propel growth of the market over the forecast period
The global thrombectomy devices market is estimated to exhibit a CAGR of 7.4% over the forecast period.
Among regions, Europe is expected to account for significant revenue share during the forecast period.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.